There is on-going development of  generic EU CTD Dossier of  Candesartan and Candesartan+HCTZ, tablets.
Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

• Croatia - Pharmaceuticals and Biotechnology (18/10/2008)
• Leading Drug Delivery Companies and Technologies (14/10/2008)
• Valuing Pharmaceutical Innovation (14/10/2008)

• Atorvastatin (31/12/2005)
• Aripiprazole (31/12/2005)
• Tamoxifen (18/12/2005)
• Simvastatin (18/12/2005)
• Ofloxacin (18/12/2005)
• Lisinopril (18/12/2005)
• Lamotrigine (18/12/2005)
• Citalopram (16/12/2005)
• Ciprofloxacine, tablets (16/12/2005)